MedTrace Logo

A Validation Study of the German Autobiographical Memory Interview

NCT04516863 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-08-18

No results posted yet for this study

Summary

Electroconvulsive therapy (ECT) is recommended for the treatment of severe depression. But, despite the high remission rates the use of ECT is strongly limited by the social stigma and treatment-emergent cognitive side effects in patients. The most relevant is retrograde amnesia (RA), because it can persists for months and years. To measure RA after ECT the short-form of the Autobiographical Memory Interview (SF-AMI) is commonly used. However, the validation of the German SF-AMI has not yet been carried out. Thus, the aim of this study is to validate the German SF-AMI in depressed patient and healthy controls.

The investigators hypothesize that the German SF-AMI is reliable and valid to quantify RA.

Conditions

  • Retrograde Amnesia

Interventions

DIAGNOSTIC_TEST

German Autobiographical Memory Interview short-form

Diagnostic Test

Sponsors & Collaborators

  • Johannes Gutenberg University Mainz

    collaborator OTHER

  • Rheinhessen-Fachklinik Alzey

    lead OTHER

Principal Investigators

  • Sarah PD Dr. med. MSc. Kayser, MD · Rheinhessen-Fachklinik Alzey

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-15
Primary Completion
2021-05-01
Completion
2021-05-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04516863 on ClinicalTrials.gov